{"id":"W4379229461","doi":"10.17925/ee.2023.19.1.4","title":"Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes","year":2023,"lang":"en","type":"editorial","venue":"touchREVIEWS in Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk; Eli Lilly and Company","keywords":"Insulin degludec; Insulin; Basal insulin; Basal (medicine); Diabetes mellitus; Internal medicine; Endocrinology; Medicine; Type 2 diabetes","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001181733,0.0006870534,0.002483447,0.001298575,0.00008754071,0.00004865147,0.0008291922,0.0009542888,0.0004247306],"category_scores_gemma":[0.01113998,0.0005841461,0.0004596193,0.001283869,0.0002878404,0.00008244126,0.0006311387,0.001978602,0.002531267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003875347,"about_ca_system_score_gemma":0.0007275005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006260266,"about_ca_topic_score_gemma":0.0001463731,"domain_scores_codex":[0.9945585,0.0003394101,0.001293928,0.001189642,0.0007397003,0.00187878],"domain_scores_gemma":[0.9950511,0.002796376,0.0003417303,0.001102675,0.0004829056,0.0002252219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002440586,0.0002040008,0.0004516252,0.003985009,0.0003086519,0.0001803487,0.00002246566,0.000003793071,0.00002494735,0.0001837942,0.9171556,0.0772357],"study_design_scores_gemma":[0.0034902,0.001316483,0.000450619,0.001220569,0.0003175285,5.730971e-7,0.00001760353,0.0002009608,0.00003558208,0.0008796201,0.9915856,0.0004846995],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.001313672,0.04961867,0.00001691406,0.002573565,0.9371399,0.004420345,0.0003195563,0.0003472356,0.004250173],"genre_scores_gemma":[0.0003155041,0.1397704,0.001205284,0.0007225496,0.8067229,0.002663387,0.007718835,0.0004434828,0.04043765],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.130417,"threshold_uncertainty_score":0.999661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06654568717830117,"score_gpt":0.3821735055999999,"score_spread":0.3156278184216987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}